Nektar Therapeutics
USD59.23
+0.67 (+1.14%)
CEO
Howard W. Robin
IPO Date
1994-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$58.51
Prev. Close
$58.56
Day Low
$58.16
Day High
$60.07
52W Low
$7.99
52W High
$109.00
Market Cap
$1.16B
Volume
0.89M
| 199 |
| $65.51 |
| 21 May 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 444 | $65.51 |
| 20 Feb 2026 | Zalevsky Jonathan | Chief R&D Officer | S-Sale | Disposed | 180 | $73.00 |
| 20 Feb 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 423 | $73.00 |
| 22 Jan 2026 | Zalevsky Jonathan | Chief R&D Officer | S-Sale | Disposed | 3,867 | $35.67 |
| 23 Dec 2025 | Zalevsky Jonathan | Chief R&D Officer | A-Award | Acquired | 6,250 | $0.00 |
| 23 Dec 2025 | Zalevsky Jonathan | Chief R&D Officer | A-Award | Acquired | 25,000 | $43.48 |
| 23 Dec 2025 | ROBIN HOWARD W | director, officer: President & CEO | A-Award | Acquired | 21,667 | $0.00 |
| 23 Dec 2025 | ROBIN HOWARD W | director, officer: President & CEO | A-Award | Acquired | 86,667 | $43.48 |